One of the primary ways calcineurin affects tumor growth is through the modulation of the immune system. Calcineurin inhibitors, such as cyclosporine and tacrolimus, are used as immunosuppressive drugs in organ transplantation to prevent rejection. However, their immunosuppressive properties can also reduce the body's ability to detect and destroy cancer cells, potentially leading to an increased risk of certain cancers.
